{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-031043","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.127133+00:00","generated_at":"2026-06-22T02:36:01.717083+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AIM ImmunoTech say-on-pay fails at 2022 annual meeting; directors elected","bullets":["Directors elected: Thomas K. Equels (7.65M for, 4.71M withheld), William M. Mitchell (4.33M for, 8.03M withheld), Stewart L. Appelrouth (4.32M for, 8.04M withheld).","Ratification of BDO USA as auditor passed: 19.95M for, 1.88M against, 0.37M abstain.","Non-binding advisory vote on executive compensation failed: 2.04M for, 10.21M against, 0.11M abstain, with 9.83M broker non-votes.","Approximately 48.05M shares eligible to vote; quorum of 40% met."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-031043","json":"https://secwatch.observer/filing/0001493152-22-031043.json","markdown":"https://secwatch.observer/filing/0001493152-22-031043.md","text":"https://secwatch.observer/filing/0001493152-22-031043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T02:36:01.717083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f9c0a5c9be229aeaae30bd9c041ee46ba08a2bd","claim":"AIM ImmunoTech Inc. shareholders approved Ratification of the selection of BDO USA, LLP as the Company's independent auditors for the fiscal year ending December 31, 2022 at the 2022-11-03 meeting.","evidence_excerpt":"Ratification of the selection of BDO USA, LLP as the Company’s independent auditors for the fiscal year ending December 31, 2022 : For: 19,946,910 Against: 1,876,423 Abstain: 366,347","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-03"}],"fact_type":"shareholder_vote"},{"claim_id":"2f1b6539c0798d7fd2e373ce5e359e5b0cddfcbc","claim":"AIM ImmunoTech Inc. shareholders approved Election of Directors at the 2022-11-03 meeting.","evidence_excerpt":"Election of Directors : The following three director nominees were each elected to serve a term ending at the Company’s Annual Meeting of Stockholders for 2023, or until their successors are duly elected and qualified: Nominees For Withheld Broker Non-Votes Thomas K. Equels 7,652,988 4,705,546 9,831,146 William M. Mitchell 4,330,110 8,028,424 9,831,146 Stewart L. Appelrouth 4,319,085 8,039,449 9,831,146","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-03"}],"fact_type":"shareholder_vote"},{"claim_id":"dfcf0a261a7c81b737f6afa9277c371a35d3860e","claim":"AIM ImmunoTech Inc. shareholders rejected Approval, by non-binding vote, of executive compensation at the 2022-11-03 meeting.","evidence_excerpt":"Approval, by non-binding vote, of executive compensation : For: 2,036,994 Against: 10,213,253 Abstain: 108,287 Broker Non-Votes: 9,831,146","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315222031043/0001493152-22-031043-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2022-11-03"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}